Traws Pharma Inc.

02/07/2024 | Press release | Archived content

Rigosertib Demonstrates Considerable Efficacy and Safety in the Treatment of Advanced/Metastatic Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic[...]